Khurram Jamil, Chief Medical Officer at Galectin Therapeutics, sold GALT on Jun 26, 2026
Data as of Oct 27
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
GALT since disclosure
−27.2%
after the sale
Similar stocks (XLV) since disclosure
+12.9%
XLV — its sector index fund
Change in closing price from Jun 30, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLKhurram Jamil Chief Medical OfficerGALT Galectin Therapeutics Inc$239Kdisclosed Jun 30 · filed 1 day after the trade
- ▼ SELLKhurram Jamil Chief Medical OfficerGALT Galectin Therapeutics Inc$12.7Kdisclosed Jun 30 · filed 4 days after the trade